128 related articles for article (PubMed ID: 8061266)
1. Use of ketanserin in the treatment of hypertension following coronary artery surgery.
Vandenbroucke G; Foubert L; Coddens J; DeLoof T; Evenepoel MC
J Cardiothorac Vasc Anesth; 1994 Jun; 8(3):324-9. PubMed ID: 8061266
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic effects of ketanserin following coronary artery bypass grafting.
Lee EJ; Lee TL; Woo M; Boey WK; Kumar A; Lee CN
Anaesth Intensive Care; 1991 Aug; 19(3):351-6. PubMed ID: 1767902
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic effects of ketanserin in the treatment of hypertension following CABG: a double-blind, placebo-controlled study.
Vandenbroucke G; Foubert L; Evenepoel MC
J Cardiothorac Anesth; 1989 Oct; 3(5 Suppl 1):3. PubMed ID: 2520966
[No Abstract] [Full Text] [Related]
4. Effect of ketanserin on sodium nitroprusside requirements, arterial pressure control and heart rate following coronary artery bypass surgery.
Hodsman NB; Colvin JR; Kenny GN
Br J Anaesth; 1989 May; 62(5):527-31. PubMed ID: 2786422
[TBL] [Abstract][Full Text] [Related]
5. A comparison of prostacyclin and sodium nitroprusside for the treatment of heart failure after cardiac surgery.
Kieler-Jensen N; Houltz E; Ricksten SE
J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):641-6. PubMed ID: 8664453
[TBL] [Abstract][Full Text] [Related]
6. [Ketanserin versus sodium nitroprusside in the treatment of hypertension following coronary surgery. Effect on intrapulmonary right and left shunt and arterial oxygenation].
Möllhoff T; Mulier JP; Müller E; Van Aken H; Lauwers P
Anaesthesist; 1989 Oct; 38(10):519-24. PubMed ID: 2686485
[TBL] [Abstract][Full Text] [Related]
7. A randomized multicenter double-blind comparison of urapidil and ketanserin in hypertensive patients after coronary artery surgery.
van der Stroom JG; van Wezel HB; Langemeijer JJ; Korsten HH; Kooyman J; van der Starre PJ; Kal JE; Porsius M; van den Ende R; van Zwieten PA
J Cardiothorac Vasc Anesth; 1997 Oct; 11(6):729-36. PubMed ID: 9327314
[TBL] [Abstract][Full Text] [Related]
8. Cardiorespiratory response of intravenous angiotensin-converting enzyme inhibitor enalaprilat in hypertensive cardiac surgery patients.
Boldt J; Schindler E; Wollbrück M; Görlach G; Hempelmann G
J Cardiothorac Vasc Anesth; 1995 Feb; 9(1):44-9. PubMed ID: 7718754
[TBL] [Abstract][Full Text] [Related]
9. Comparison of nicardipine and sodium nitroprusside in the treatment of paroxysmal hypertension following aortocoronary bypass surgery.
David D; Dubois C; Loria Y
J Cardiothorac Vasc Anesth; 1991 Aug; 5(4):357-61. PubMed ID: 1873513
[TBL] [Abstract][Full Text] [Related]
10. Effects of urapidil, ketanserin and sodium nitroprusside on venous admixture and arterial oxygenation following coronary artery bypass grafting.
Möllhoff T; Van Aken H; Mulier JP; Müller E; Lauwers P
Br J Anaesth; 1990 Apr; 64(4):493-7. PubMed ID: 2334625
[TBL] [Abstract][Full Text] [Related]
11. A comparison of fenoldopam and nitroprusside in the control of hypertension following coronary artery surgery.
Hill AJ; Feneck RO; Walesby RK
J Cardiothorac Vasc Anesth; 1993 Jun; 7(3):279-84. PubMed ID: 8100152
[TBL] [Abstract][Full Text] [Related]
12. Treatment of postoperative hypertension after coronary artery bypass surgery. Double-blind comparison of intravenous isradipine and sodium nitroprusside.
Leslie J; Brister N; Levy JH; Yared JP; Marty A; Martin H; Hines R; Savino J; Cohen M
Circulation; 1994 Nov; 90(5 Pt 2):II256-61. PubMed ID: 7955262
[TBL] [Abstract][Full Text] [Related]
13. Ketanserin in the treatment of systemic hypertension during and following coronary artery bypass surgery.
van der Starre PJ; Reneman RS; Scheijgrond HW
Angiology; 1989 Nov; 40(11):1001-10. PubMed ID: 2510560
[TBL] [Abstract][Full Text] [Related]
14. Use of isradipine in hypertension following coronary artery bypass surgery.
Underwood SM; Feneck RO; Davies SW; Walesby RK; Lunnon MW
Am J Med; 1989 Apr; 86(4A):81-7. PubMed ID: 2523661
[TBL] [Abstract][Full Text] [Related]
15. Nitroprusside and ketanserin in the treatment of postoperative hypertension following coronary artery bypass grafting: a haemodynamic and ventilatory comparison.
van der Starre PJ; Harinck-de Weerd JE; Reneman RS
J Hypertens Suppl; 1986 Apr; 4(1):S107-10. PubMed ID: 2939209
[TBL] [Abstract][Full Text] [Related]
16. Intravenous labetalol versus sodium nitroprusside for treatment of hypertension postcoronary bypass surgery.
Cruise CJ; Skrobik Y; Webster RE; Marquez-Julio A; David TE
Anesthesiology; 1989 Dec; 71(6):835-9. PubMed ID: 2686494
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of nicardipine and nitroprusside in preventing poststernotomy hypertension.
van Wezel HB; Koolen JJ; Visser CA; Vergroesen I; Leyssius AT; Dijkhuis JP; Meyne NG; Deen L
J Cardiothorac Anesth; 1989 Dec; 3(6):700-6. PubMed ID: 2521026
[TBL] [Abstract][Full Text] [Related]
18. The use of ketanserin, a 5-hydroxytryptamine receptor antagonist, for treatment of postoperative hypertension following coronary artery bypass surgery.
van der Starre PJ; Scheijgrond HW; Reneman RS; Kolling JB
Anesth Analg; 1983 Jan; 62(1):63-9. PubMed ID: 6600382
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular effects of ketanserin in the treatment of hypertension during coronary artery bypass surgery.
Richter JA; Barankay A; Göb E; Späth P
J Cardiovasc Pharmacol; 1986; 8(1):109-15. PubMed ID: 2419672
[TBL] [Abstract][Full Text] [Related]
20. Systemic hypertension in low-gradient severe aortic stenosis with preserved ejection fraction.
Eleid MF; Nishimura RA; Sorajja P; Borlaug BA
Circulation; 2013 Sep; 128(12):1349-53. PubMed ID: 23956211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
